Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3046% above fair value
$29.45+0.09 (+0.31%)
Close on Nov 11, 2026Market cap $167.86BP/E 42.1Yield 5.84%
Pfizer ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Pfizer
Pfizer has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?